Tissue engineering the small intestine

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 4, 2013, Pages 354-358

  Spurrier, Ryan G ^a   Grikscheit, Tracy C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Organoid Unit; Regeneration; Short Bowel Syndrome; Small Intestine; Stem Cell; Tissue Engineering

Indexed keywords

ACTIVIN A; COLLAGEN TYPE 1; FIBROBLAST GROWTH FACTOR; NEUROGENIN 3; TISSUE SCAFFOLD; WNT3A PROTEIN;

ANGIOGENESIS; ARTICLE; AUTOTRANSPLANTATION; CELL ADHESION; CELL DIFFERENTIATION; CELL MATURATION; DONOR; ENTEROENDOCRINE CELL; HUMAN; MESENCHYMAL STEM CELL; MORPHOGENESIS; NERVE CELL GROWTH; NONHUMAN; OMENTUM; PLURIPOTENT STEM CELL; SHORT BOWEL SYNDROME; SMALL INTESTINE; SMALL INTESTINE MUCOSA; TISSUE ENGINEERING; VASCULARIZATION;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INTESTINE, SMALL; MICE; RATS; REGENERATIVE MEDICINE; SHORT BOWEL SYNDROME; SWINE; TISSUE ENGINEERING;

EID: 84875365215     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.01.028     Document Type: Article

References (54)

1. Wales P.W., de Silva N., Kim J., et al. Neonatal short bowel syndrome: population-based estimates of incidence and mortality rates. J Pediatr Surg 2004, 39:690-695.
2. Grikscheit T.C., Vacanti J.P. The history and current status of tissue engineering: the future of pediatric surgery. J Pediatr Surg 2002, 37:277-288.
3. Ueno T., Fukuzawa M. Current status of intestinal transplantation. Surg Today 2010, 40:1112-1122.
4. Peyret B., Collardeau S., Touzet S., et al. Prevalence of liver complications in children receiving long-term parenteral nutrition. Eur J Clin Nutr 2011, 65:743-749.
5. Fallon E.M., Le H.D., Puder M. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil. Curr Opin Organ Transplant 2010, 15:334-340.
6. Meisel J.A., Le H.D., de Meijer V.E., et al. Comparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model. J Pediatr Surg 2011, 46:666-673.
7. Jeppesen P.B., Gilroy R., Pertkiewicz M., et al. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut 2011, 60:902-914.
8. Jeppesen P.B., Pertkiewicz M., Messing B., et al. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology 2012, 143:1473-1481.
9. Jeppesen P.B. Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome. Therap Adv Gastroenterol 2012, 5:159-171.
10. Rege A.S., Sudan D.L. Autologous gastrointestinal reconstruction: review of the optimal nontransplant surgical options for adults and children with short bowel syndrome. Nutr Clin Pract 2012, 28:65-74.
11. Jones B.A., Hull M.A., Kim H.B. Autologous intestinal reconstruction surgery for intestinal failure management. Curr Opin Organ Transplant 2010, 15:341-345.
12. LaRosa C., Baluarte H.J., Meyers K.E. Outcomes in pediatric solid-organ transplantation. Pediatr Transplant 2011, 15:128-141.
13. LaRosa C., Glah C., Baluarte H.J., et al. Solid-organ transplantation in childhood: transitioning to adult health care. Pediatrics 2011, 127:742-753.
14. Garg M., Jones R.M., Vaughan R.B., et al. Intestinal transplantation: current status and future directions. J Gastroenterol Hepatol 2011, 26:1221-1228.
15. Lao O.B., Healey P.J., Perkins J.D., et al. Outcomes in children with intestinal failure following listing for intestinal transplant. J Pediatr Surg 2010, 45:100-107.
16. Wales P.W., Christison-Lagay E.R. Short bowel syndrome: epidemiology and etiology. Semin Pediatr Surg 2010, 19:3-9.
17. Lao O.B., Healey P.J., Perkins J.D., et al. Outcomes in children after intestinal transplant. Pediatrics 2010, 125:e550-e558.
18. Potten C.S., Gandara R., Mahida Y.R., et al. The stem cells of small intestinal crypts: where are they?. Cell Prolif 2009, 42:731-750.
19. Moore K.A., Lemischka I.R. Stem cells and their niches. Science 2006, 311:1880-1885.
20. Garcia M.I., Ghiani M., Lefort A., et al. LGR5 deficiency deregulates Wnt signaling and leads to precocious Paneth cell differentiation in the fetal intestine. Dev Biol 2009, 331:58-67.
21. Gregorieff A., Stange D.E., Kujala P., et al. The ets-domain transcription factor Spdef promotes maturation of goblet and Paneth cells in the intestinal epithelium. Gastroenterology 2009, 137:1333-1345.
22. Farin H.F., Van Es J.H., Clevers H. Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells. Gastroenterology 2012, 143:1518-1529.
23. Bjerknes M., Cheng H. The stem-cell zone of the small intestinal epithelium: IV-effects of resecting 30% of the small intestine. Am J Anat 1981, 160:93-103.
24. Cheng H., Leblond C.P. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine: I-columnar cell. Am J Anat 1974, 141:461-479.
25. Cheng H., Leblond C.P. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine: V-unitarian theory of the origin of the four epithelial cell types. Am J Anat 1974, 141:537-561.
26. Barker N., van Es J.H., Kuipers J., et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1007.
27. Sangiorgi E., Capecchi M.R. Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet 2008, 40:915-920.
28. Li L., Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science 2010, 327:542-545.
29. Dijkmans T.F., van Hooijdonk L.W., Fitzsimons C.P., et al. The doublecortin gene family and disorders of neuronal structure. Cent Nerv Syst Agents Med Chem 2010, 10:32-46.
30. May R., Sureban S.M., Hoang N., et al. Doublecortin and CaM kinase-like-1 and leucine-rich-repeat-containing G-protein-coupled receptor mark quiescent and cycling intestinal stem cells, respectively. Stem Cells 2009, 27:2571-2579.
31. Zhu L., Gibson P., Currle D.S., et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 2009, 457:603-607.
32. Asai R., Okano H., Yasugi S. Correlation between Musashi-1 and c-hairy-1 expression and cell proliferation activity in the developing intestine and stomach of both chicken and mouse. Dev Growth Differ 2005, 47:501-510.
33. Montgomery R.K., Carlone D.L., Richmond C.A., et al. Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells. Proc Natl Acad Sci U S A 2011, 108:179-184.
34. Evans G.S., Flint N., Somers A.S., et al. The development of a method for the preparation of rat intestinal epithelial cell primary cultures. J Cell Sci 1992, 101:219-231.
35. Vacanti J.P., Morse M.A., Saltzman W.M., et al. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg 1988, 23:3-9.
36. Speer A.L., Sala F.G., Matthews J.A., et al. Murine tissue-engineered stomach demonstrates epithelial differentiation. J Surg Res 2011, 171:6-14.
37. Sala F.G., Matthews J.A., Speer A.L., et al. A multicellular approach forms a significant amount of tissue-engineered small intestine in the mouse. Tissue Eng Part A 2011, 17:1841-1850.
38. Grikscheit T., Ochoa E.R., Srinivasan A., et al. Tissue-engineered esophagus: experimental substitution by onlay patch or interposition. J Thorac Cardiovasc Surg 2003, 126:537-544.
39. Grikscheit T.C., Ochoa E.R., Ramsanahie A., et al. Tissue-engineered large intestine resembles native colon with appropriate in vitro physiology and architecture. Ann Surg 2003, 238:35-41.
40. Grikscheit T.C., Siddique A., Ochoa E.R., et al. Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg 2004, 240:748-754.
41. Grikscheit T.C., Ogilvie J.B., Ochoa E.R., et al. Tissue-engineered colon exhibits function in vivo. Surgery 2002, 132:200-204.
42. Sala F.G., Kunisaki S.M., Ochoa E.R., et al. Tissue-engineered small intestine and stomach form from autologous tissue in a preclinical large animal model. J Surg Res 2009, 156:205-212.
43. Salerno-Goncalves R., Fasano A., Sztein M.B. Engineering of a multicellular organotypic model of the human intestinal mucosa. Gastroenterology 2011, 141:e18-e20.
44. Sato T., Vries R.G., Snippert H.J., et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009, 459:262-265.
45. Barthel E.R., Levin D.E., Speer A.L., et al. Human tissue-engineered colon forms from postnatal progenitor cells: an in vivo murine model. Regen Med 2012, 7:807-818.
46. Levin D.E., Barthel E.R., Speer A.L., et al. Human tissue-engineered small intestine forms from postnatal progenitor cells. J Pediatr Surg 2013, 48:129-137.
47. Ott H.C. Engineering tissues for children: building grafts that grow. Lancet 2012, 380:957-958.
48. Xu H.M., Wang Z.J., Han J.G., et al. Application of acellular dermal matrix for intestinal elongation in animal models. World J Gastroenterol 2010, 16:2023-2027.
49. Orlando G., Baptista P., Birchall M., et al. Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transpl Int 2011, 24:223-232.
50. Bhrany A.D., Beckstead B.L., Lang T.C., et al. Development of an esophagus acellular matrix tissue scaffold. Tissue Eng 2006, 12:319-330.
51. Voytik-Harbin S.L., Brightman A.O., Kraine M.R., et al. Identification of extractable growth factors from small intestinal submucosa. J Cell Biochem 1997, 67:478-491.
52. Hodde J.P., Record R.D., Liang H.A., et al. Vascular endothelial growth factor in porcine-derived extracellular matrix. Endothelium 2001, 8:11-24.
53. McDevitt C.A., Wildey G.M., Cutrone R.M. Transforming growth factor-beta1 in a sterilized tissue derived from the pig small intestine submucosa. J Biomed Mater Res A 2003, 67:637-640.
54. Spence J.R., Mayhew C.N., Rankin S.A., et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 2011, 470:105-109.